Log In
BCIQ
Print this Print this
 

Feiba VH

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionSterile human plasma fraction composed of blood-clotting proteins other than Factor VIII
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat hemophilia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$30,000.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/03/2016

$30,000.0M

0

0

Get a free BioCentury trial today